| scholarly article | Q13442814 |
| P356 | DOI | 10.1530/ERC-12-0398 |
| P698 | PubMed publication ID | 23507704 |
| P50 | author | Ja Seung Koo | Q59682030 |
| P2093 | author name string | Do Hee Kim | |
| Woo-Hee Jung | |||
| Sewha Kim | |||
| P2860 | cites work | Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction | Q29616653 |
| P433 | issue | 3 | |
| P921 | main subject | breast cancer | Q128581 |
| P304 | page(s) | 339-348 | |
| P577 | publication date | 2013-05-21 | |
| P1433 | published in | Endocrine-Related Cancer | Q3054004 |
| P1476 | title | Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer | |
| P478 | volume | 20 |
| Q38651973 | ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma |
| Q37023688 | ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. |
| Q57110643 | Amino Acid Metabolism as a Target for Breast Cancer Imaging |
| Q54957053 | Amino Acid Transporters and Glutamine Metabolism in Breast Cancer. |
| Q94562053 | Amino acid transporters: Emerging roles in drug delivery for tumor-targeting therapy |
| Q58804578 | An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models |
| Q92459542 | Assessing Metabolic Intervention with a Glutaminase Inhibitor in Real-Time by Hyperpolarized Magnetic Resonance in Acute Myeloid Leukemia |
| Q57952962 | Cryo-EM structure of the human neutral amino acid transporter ASCT2 |
| Q47836759 | Deciphering metabolic rewiring in breast cancer subtypes |
| Q33825671 | Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. |
| Q35159467 | Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. |
| Q91826226 | Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer |
| Q94475854 | Enhanced glutamine utilization mediated by SLC1A5 and GPT2 is an essential metabolic feature of colorectal signet ring cell carcinoma with therapeutic potential |
| Q47271637 | Evaluation of the Expression of Amine Oxidase Proteins in Breast Cancer. |
| Q55220853 | Expression of Pentose Phosphate Pathway-Related Proteins in Breast Cancer. |
| Q37619803 | Expression of glutamine metabolism-related proteins in thyroid cancer |
| Q87428911 | Expression of metabolism-related proteins in invasive lobular carcinoma: comparison to invasive ductal carcinoma |
| Q36982043 | Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. |
| Q87800507 | Extraction of Molecular Features through Exome to Transcriptome Alignment |
| Q55284992 | Global metabolite profiling analysis of lipotoxicity in HER2/neu-positive breast cancer cells. |
| Q40341736 | Glutaminase expression is a poor prognostic factor in node-positive triple-negative breast cancer patients with a high level of tumor-infiltrating lymphocytes |
| Q92715598 | Glutamine Metabolism Drives Growth in Advanced Hormone Receptor Positive Breast Cancer |
| Q64055841 | Glutamine to proline conversion is associated with response to glutaminase inhibition in breast cancer |
| Q57174877 | Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2 |
| Q35235735 | IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth |
| Q33712426 | Implications of differences in expression of sarcosine metabolism-related proteins according to the molecular subtype of breast cancer. |
| Q47370695 | MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer |
| Q49871101 | Metabolic Footprints and Molecular Subtypes in Breast Cancer |
| Q58750642 | Metabolic Targeting of Breast Cancer Cells With the 2-Deoxy-D-Glucose and the Mitochondrial Bioenergetics Inhibitor MDIVI-1 |
| Q34967995 | Metabolic characterization of triple negative breast cancer |
| Q54350939 | Metabolic differences in estrogen receptor-negative breast cancer based on androgen receptor status. |
| Q37493948 | Metabolic phenotypes in primary unknown metastatic carcinoma. |
| Q65001698 | Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. |
| Q26767022 | Targeting metabolism in breast cancer: How far we can go? |
| Q47326513 | The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ. |
| Q38170895 | The role of FAK in tumor metabolism and therapy. |
| Q92591525 | mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance |
Search more.